Method of preventing aggravation of a disease involving a biological mechanism controlled by a dendritic cell immunoreceptor
AssigneeTokyo University of Science Foundation
InventorsYoichiro Iwakura, Tomonori Kaifu
Life of this patent
Estimating the term…
Abstract
Provided are: a pharmaceutical composition for curing, treating, or preventing a disease involving a biological mechanism controlled by a dendritic cell immunoreceptor, in which the pharmaceutical composition contains a carbohydrate modifying enzyme as an active ingredient; and a method of curing, treating, or preventing a disease involving a biological mechanism controlled by a dendritic cell immunoreceptor.
Claims5
A method of preventing aggravation of a disease involving a biological mechanism controlled by a dendritic cell immunoreceptor, the method comprising administering an effective amount of a carbohydrate modifying enzyme to a subject in need of preventing aggravation of the disease, wherein the carbohydrate modifying enzyme is neuraminidase and wherein the disease is an osteometabolic disease or an autoimmune disease.
Dependencies are inferred from the claim text.